Osella G, Orlandi F, Caraci P, Ventura M, Deandreis D, Papotti M, Bongiovanni M, Angeli A, Terzolo M
Department of Biological and Clinical Sciences, University of Turin, Turin, Italy.
J Endocrinol Invest. 2003 Feb;26(2):163-9. doi: 10.1007/BF03345146.
GH hyperproduction due to ectopic secretion of GHRH is a rare cause of acromegaly. Since 1959, approximately 50 cases of ectopic GHRH production from extrapituitary tumors have been described. Here we report the clinical and biochemical features of a 47-yr-old Caucasian woman with ectopic GHRH syndrome sustained by a bronchial carcinoid. The criteria for the diagnosis of acromegaly due to ectopic GHRH secretion were satisfied in our patient (i.e. confirmation of active GH hypersecretion, unequivocal demonstration of GHRH production and secretion from an extrapituitary tumor and cure of acromegaly after neoplasm removal). The tumor was an atypical carcinoid and there was a familial history of lung and colorectal cancer. Acromegaly was slightly active (mean GH value: 7.4 ng/ml, IGF-I: 436 ng/ml) and after tumor removal there was a progressive decline of GH levels, consistent with remission of pituitary somatotroph hyperplasia. Pituitary radiology showed an empty sella demonstrating for the first time its association with ectopic GHRH syndrome.
由于生长激素释放激素(GHRH)异位分泌导致的生长激素(GH)过度分泌是肢端肥大症的罕见病因。自1959年以来,已报道了约50例源于垂体外肿瘤的异位GHRH分泌病例。在此,我们报告一名47岁患有支气管类癌所致异位GHRH综合征的白种女性的临床和生化特征。我们的患者满足因异位GHRH分泌导致肢端肥大症的诊断标准(即证实存在活跃的GH分泌过多、明确证明垂体外肿瘤产生并分泌GHRH以及肿瘤切除后肢端肥大症得以治愈)。该肿瘤为非典型类癌,且有肺癌和结直肠癌家族史。肢端肥大症处于轻度活动期(平均GH值:7.4 ng/ml,胰岛素样生长因子-I:436 ng/ml),肿瘤切除后GH水平逐渐下降,这与垂体生长激素细胞增生缓解一致。垂体影像学检查显示为空蝶鞍,首次证明其与异位GHRH综合征有关。